SHR-1316

· Jiangsu HengRui Medicine Co., Ltd.

Drug timelines are a Plus or Pro feature.

15 regulatory and trial events tracked for SHR-1316, covering 2018-03-22 to 2026-04-20. Get the full timeline:

Most recent: Clinical Trial Update: A Trial of Injectable SHR-A1811 in Combination With Pyrotinib or SHR-1316 in Subjects With Advanced Non-small Cell Lung Cancer [Phase 1, Phase 2]

See pricing